Who
Carlos Luis Lopez
SVP, General Counsel
Company insider
Files Form 4 as: SVP, General Counsel, Niagen Bioscience.
In numbers
- Trades disclosed
- 6
- Buys
- 1
- Sells
- 0
- Bought
- $2,146
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 12 Feb 2025
- Last trade
- 30 Jun 2026
- Last filed
- 8 Jul 2026
Companies traded
Activity over time
1 Mar 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 30 Jun 2026filed 8 Jul 2026 | NAGE Niagen BiosciencePharmaceuticals | SEC FORM 4 Code A | $6,2712,314 at $2.71 | filing |
| 30 Jun 2026filed 8 Jul 2026 | NAGE Niagen BiosciencePharmaceuticals | SEC FORM 4 Code A | $6,2712,314 at $2.71 | filing |
| 19 Feb 2026filed 24 Feb 2026 | NAGE Niagen Bioscienceoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —41,420 at $0.00 | filing |
| 19 Feb 2026filed 24 Feb 2026 | NAGE Niagen Bioscienceoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —41,420 at $0.00 | filing |
| 7 Mar 2025filed 10 Mar 2025 | NAGE Niagen BiosciencePharmaceuticals | SEC FORM 4 Bought | $2,146273 at $7.86 | filing |
| 12 Feb 2025filed 14 Feb 2025 | NAGE Niagen Bioscienceoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —19,691 at $0.00 | filing |
News
Restore Hyper Wellness® and Niagen Bioscience Team Up to Help Americans Age Better This OctoberNAGE · prnewswire.com · 8 Oct 2026
0 headlines in the last 90 days name Carlos Luis Lopez; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.